Overview of dsm-firmenich's Share Repurchase Program
dsm-firmenich, a leader in nutrition, health, and beauty solutions, has embarked on an ambitious share repurchase program aimed at enhancing shareholder value. The initiative, initially announced in early 2025, is structured to repurchase ordinary shares totaling €1 billion, with a strategic focus on covering share-based compensation commitments and reducing issued capital.
Recent Developments in the Share Repurchase Program
As part of its ongoing efforts, dsm-firmenich started the share repurchase program on April 1, 2025. The initial financial commitment was substantial, with €580 million allocated for repurchase activities. This included €80 million designated for fulfilling obligations related to the company’s share plans, while the remaining €500 million focused on capital reduction.
By June 2025, dsm-firmenich announced an increase in the total value of the program to €1,080 million. This adjustment followed a successful sale of its stake in the Feed Enzymes Alliance, which allowed the company to strengthen its financial position and expand its strategic investments.
Progress and Current Status
The company has been actively progressing with its repurchase goals. During the week of November 17, 2025, it reported repurchases amounting to 418,989 shares, completed at an average price of €70.36 per share. This equated to an investment of approximately €29.5 million during that period. Altogether, the cumulative total of shares repurchased under the program now stands at an impressive 12,479,846 shares, with total spending around €1,048 million at an average price of €83.98 per share.
Future Timeline
Looking ahead, dsm-firmenich has established a clear timeline for completing the program. The company aims to finalize the share repurchases by January 30, 2026. This commitment reflects dsm-firmenich's dedication to maintaining robust shareholder engagement while ensuring financial health.
About dsm-firmenich
dsm-firmenich is at the forefront of innovation in nutrition and health. The company, with dual headquarters in Switzerland and the Netherlands, works diligently to develop vital nutrients and flavors that cater to a global audience. With operations spanning nearly 60 countries and annual revenues exceeding €12 billion, the company employs a diverse workforce of approximately 30,000 individuals dedicated to bringing innovative solutions to life.
dsm-firmenich thrives on ensuring sustainability through its scientifically proven products and practices. Their holistic approach focuses on delivering what is essential for life while also being desirable for consumers. As the world evolves, dsm-firmenich remains committed to providing sustainable solutions that benefit both people and the planet.
Frequently Asked Questions
What is the primary goal of the dsm-firmenich share repurchase program?
The primary goal of the share repurchase program is to enhance shareholder value while also meeting obligations related to employee compensation through share plans.
How much has been committed to the share repurchase program?
Initially, €1 billion has been earmarked for the share repurchase program, with adjustments increasing the total to €1,080 million.
When will the share repurchase program be completed?
The share repurchase program is set to be completed no later than January 30, 2026.
What is the latest update on the number of shares repurchased?
To date, dsm-firmenich has repurchased a total of 12,479,846 shares under the program.
What markets does dsm-firmenich operate in?
dsm-firmenich operates in nearly 60 countries worldwide, catering to various sectors in nutrition, health, and beauty.
